Aerospace Medicine Safety Information System (AMSIS) Market Survey/Request for Information (RFI) Announcement Seeking Generic Drug Monograph Data Supplier

The pupose of this amendment to the Market Survey is to extend the response due date to September 30, 2021. The Federal Aviation Administration (FAA) Aerospace Medicine Safety Information System (AMSIS) Program Office (PO) is searching for a vendor that can, on a regular basis, provide the latest information on medications based on their generic form. This includes an adult drug monograph that has been curated, such that warnings, contraindications, and adverse reactions are tied to the generic name. AMSIS will process the information from this dataset to automatically be alerted to new information that could affect their recommendations.